Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis III: Management
Coronary Artery Disease IV: Preventive Measures
Adrenergic Antagonists: ɑ and β-Receptor Blockers
Lipid Absorption
Bioavailability Enhancement: Drug Permeability Enhancement
こちらも読む
共著者、ジャーナル、引用グラフによってこの研究に関連する記事。
Michael C Honigberg1,2,3,4, Pradeep Natarajan1,2,3,4
1Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston.
No abstract available in PubMed .